Eric S Rovner
Overview
Explore the profile of Eric S Rovner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
1748
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rovner E
Curr Opin Urol
. 2024 Aug;
34(6):407-411.
PMID: 39105301
Purpose Of Review: There has been a need for an acceptable common minimum data set in the scientific literature as regards the surgical treatment of female stress urinary incontinence (SUI)....
2.
Cameron A, Chung D, Dielubanza E, Enemchukwu E, Ginsberg D, Helfand B, et al.
Neurourol Urodyn
. 2024 Jul;
43(8):1742-1752.
PMID: 39010271
Purpose: The purpose of this guideline is to provide evidence-based guidance to clinicians of all specialties on the evaluation, management, and treatment of idiopathic overactive bladder (OAB). The guideline informs...
3.
Cameron A, Chung D, Dielubanza E, Enemchukwu E, Ginsberg D, Helfand B, et al.
J Urol
. 2024 Apr;
212(1):11-20.
PMID: 38651651
Purpose: The purpose of this guideline is to provide evidence-based guidance to clinicians of all specialties on the evaluation, management, and treatment of idiopathic overactive bladder (OAB). The guideline informs...
4.
Dmochowski R, Newman D, Rovner E, Zillioux J, Malik R, Ackerman A
Adv Ther
. 2023 Sep;
40(11):4741-4757.
PMID: 37725308
Anticholinergics have been used in the treatment of overactive bladder (OAB), but their use is limited by poor tolerability and anticholinergic-related side effects. Increasingly, providers are discontinuing anticholinergic prescribing because...
5.
Dmochowski R, Rovner E, Kennelly M, Newman D, Abedinzadeh L, Snyder D, et al.
BMC Urol
. 2023 Apr;
23(1):64.
PMID: 37095473
Background: Overactive bladder (OAB) is defined as urinary urgency accompanied by frequency and nocturia, with or without urge urinary incontinence (UUI). Vibegron, a selective β-adrenergic receptor agonist approved in the...
6.
Versi E, Rovner E, Dmochowski R, Tu L, De Wachter S
Low Urin Tract Symptoms
. 2022 Mar;
14(4):242-247.
PMID: 35233968
Objectives: To determine if reduction in urgency in patients with refractory overactive bladder syndrome (rOAB) is correlated with a reduction in voiding frequency and symptom bother. Methods: Data from a...
7.
Ginsberg D, Boone T, Cameron A, Gousse A, Kaufman M, Keays E, et al.
J Urol
. 2021 Sep;
206(5):1106-1113.
PMID: 34495688
Purpose: The clinician treating patients with neurogenic lower urinary tract dysfunction (NLUTD) needs to balance a variety of factors when making treatment decisions. In addition to the patient's urologic symptoms...
8.
The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation
Ginsberg D, Boone T, Cameron A, Gousse A, Kaufman M, Keays E, et al.
J Urol
. 2021 Sep;
206(5):1097-1105.
PMID: 34495687
Purpose: The clinician treating patients with neurogenic lower urinary tract dysfunction (NLUTD) needs to balance a variety of factors when making treatment decisions. In addition to the patient's urologic symptoms...
9.
Andersson K, Christ G, Davies K, Rovner E, Melman A
Ther Clin Risk Manag
. 2021 Jun;
17:589-599.
PMID: 34113116
A need exists for local (ie, bladder-specific) interventions to treat overactive bladder (OAB) with low risk of unwanted postprocedural outcomes. Gene therapy targeted to leverage endogenous physiology in bladder cells...
10.
Carlson K, Rovner E, Nair K, Deal A, Kristy R, Hairston J
Low Urin Tract Symptoms
. 2021 May;
13(4):425-434.
PMID: 33987973
Objectives: This analysis from the PERSPECTIVE (a Prospective, Non-interventional Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder) study evaluated treatment persistence with mirabegron or antimuscarinics...